Chiropractic spinal manipulative therapy for cervicogenic headache: a study protocol of a single-blinded placebo-controlled randomized clinical trial

Aleksander Chaibi, Jūratė Šaltytė Benth, Peter J Tuchin, Michael Bjørn Russell, Aleksander Chaibi, Jūratė Šaltytė Benth, Peter J Tuchin, Michael Bjørn Russell

Abstract

Cervicogenic headache (CEH) is a secondary headache which affects 1.0-4.6 % of the population. Although the costs are unknown, the health consequences are substantial for the individual; especially considering that they often suffers chronicity. Pharmacological management has no or only minor effect on CEH. Thus, we aim to assess the efficacy of chiropractic spinal manipulative therapy (CSMT) for CEH in a single-blinded placebo-controlled randomized clinical trial (RCT). According to the power calculations, we aim to recruit 120 participants to the RCT. Participants will be randomized into one of three groups; CSMT, placebo (sham manipulation) and control (usual non-manual management). The RCT consists of three stages: 1 month run-in, 3 months intervention and follow-up analyses at the end of intervention and 3, 6 and 12 months. Primary end-point is headache frequency, while headache duration, headache intensity, headache index (frequency × duration × intensity) and medicine consumption are secondary end-points. Primary analysis will assess a change in headache frequency from baseline to the end of intervention and to follow-up, where the groups CSMT and placebo and CSMT and control will be compared. Due to two group-comparisons, the results with p values below 0.025 will be considered statistically significant. For all secondary end-points and analyses, the significance level of 0.05 will be used. The results will be presented with the corresponding p values and 95 % confidence intervals. To our knowledge, this is the first prospective manual therapy three-armed single-blinded placebo-controlled RCT to be conducted for CEH. Current RCTs suggest efficacy in headache frequency, duration and intensity. However a firm conclusion requires clinical single-blinded placebo-controlled RCTs with few methodological shortcomings. The present study design adheres to the recommendations for pharmacological RCTs as far as possible and follows the recommended clinical trial guidelines by the International Headache Society. Trial registration ClinicalTrials.gov identifier: NCT01687881, 2 December 2012.

Keywords: Cervicogenic headache; Chiropractic; Headache; Manual therapy; Protocol; Randomized controlled trial; Spinal manipulation.

Figures

Fig. 1
Fig. 1
Flow-chart of study
Fig. 2
Fig. 2
Expected participants flow diagram

References

    1. Aaseth K, Grande RB, Kvaerner KJ, Gulbrandsen P, Lundqvist C, Russell MB. Prevalence of secondary chronic headaches in a population-based sample of 30–44-year-old persons. The Akershus study of chronic headache. Cephalalgia. 2008;28(7):705–713. doi: 10.1111/j.1468-2982.2008.01577.x.
    1. Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Control Clin Trials. 2004;25(2):143–156. doi: 10.1016/j.cct.2003.10.016.
    1. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry. 1996;61(3):285–290. doi: 10.1136/jnnp.61.3.285.
    1. Boal RW, Gillette RG. Central neuronal plasticity, low back pain and spinal manipulative therapy. J Manipulative Physiol Ther. 2004;27(5):314–326. doi: 10.1016/j.jmpt.2004.04.005.
    1. Bogduk N. The neck and headaches. Neurol Clin. 2004;22(1):151–171. doi: 10.1016/S0733-8619(03)00100-2.
    1. Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol. 2009;8(10):959–968. doi: 10.1016/S1474-4422(09)70209-1.
    1. Borretzen I, Lysdahl KB, Olerud HM. Diagnostic radiology in Norway trends in examination frequency and collective effective dose. Radiat Prot Dosim. 2007;124(4):339–347. doi: 10.1093/rpd/ncm204.
    1. Borusiak P, Biedermann H, Bosserhoff S, Opp J. Lack of efficacy of manual therapy in children and adolescents with suspected cervicogenic headache: results of a prospective, randomized, placebo-controlled, and blinded trial. Headache. 2010;50(2):224–230. doi: 10.1111/j.1526-4610.2009.01550.x.
    1. Cassidy JD, Boyle E, Cote P, He Y, Hogg-Johnson S, Silver FL, Bondy SJ. Risk of vertebrobasilar stroke and chiropractic care: results of a population-based case–control and case-crossover study. Spine (Phila Pa 1976) 2008;15(33(4 Suppl)):S176–S183. doi: 10.1097/BRS.0b013e3181644600.
    1. Chaibi A, Russell MB. Manual therapies for cervicogenic headache: a systematic review. J Headache Pain. 2012;13(5):351–359. doi: 10.1007/s10194-012-0436-7.
    1. Chaibi A, Saltyte Benth J, Bjorn Russell M. Validation of placebo in a manual therapy randomized controlled trial. Sci Rep. 2015;5:11774. doi: 10.1038/srep11774.
    1. Cooperstein R. Gonstead chiropractic technique (GCT) J Chiropr Med. 2003;2(1):16–24. doi: 10.1016/S0899-3467(07)60069-X.
    1. Cooperstein R, Gleberson BJ. Technique systems in chiropractic. 1. New York: Churchill Livingston; 2004.
    1. Cracknell DM, Bull PW. Organ dosimetry in spinal radiography: a comparison of 3-region sectional and full-spine techniques. Chiropr J Aust. 2006;36(1):33–39.
    1. De Camargo VM, Alburquerque-Sendin F, Berzin F, Stefanelli VC, de Souza DP, Fernandez-de-las-Penas C. Immediate effects on electromyographic activity and pressure pain thresholds after a cervical manipulation in mechanical neck pain: a randomized controlled trial. J Manipulative Physiol Ther. 2011;34(4):211–220. doi: 10.1016/j.jmpt.2011.02.002.
    1. Fernandez-de-las-Penas C, Alonso-Blanco C, San-Roman J, Miangolarra-Page JC. Methodological quality of randomized controlled trials of spinal manipulation and mobilization in tension-type headache, migraine, and cervicogenic headache. J Orthop Sports Phys Ther. 2006;36(3):160–169. doi: 10.2519/jospt.2006.36.3.160.
    1. French HP, Brennan A, White B, Cusack T. Manual therapy for osteoarthritis of the hip or knee—a systematic review. Manual therapy. 2011;16(2):109–117. doi: 10.1016/j.math.2010.10.011.
    1. Grande RB, Aaseth K, Gulbrandsen P, Lundqvist C, Russell MB. Prevalence of primary chronic headache in a population-based sample of 30- to 44-year-old persons. The Akershus study of chronic headache. Neuroepidemiology. 2008;30(2):76–83. doi: 10.1159/000116244.
    1. Haas M, Groupp E, Aickin M, Fairweather A, Ganger B, Attwood M, Cummins C, Baffes L Dose response for chiropractic care of chronic cervicogenic headache and associated neck pain: a randomized pilot study. J Manipulative Physiol Ther. 2004;27(9):547–553. doi: 10.1016/j.jmpt.2004.10.007.
    1. Haas M, Spegman A, Peterson D, Aickin M, Vavrek D. Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial. Spine J. 2010;10(2):117–128. doi: 10.1016/j.spinee.2009.09.002.
    1. Hagen K, Albretsen C, Vilming ST, Salvesen R, Gronning M, Helde G, Gravdahl G, Zwart JA, Stovner LJ. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia. 2009;29(2):221–232. doi: 10.1111/j.1468-2982.2008.01711.x.
    1. Hancock MJ, Maher CG, Latimer J, McAuley JH. Selecting an appropriate placebo for a trial of spinal manipulative therapy. Aust J Physiother. 2006;52(2):135–138. doi: 10.1016/S0004-9514(06)70049-6.
    1. Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders, 3rd edition (beta version) Cephalalgia. 2013;33(9):629–808. doi: 10.1177/0333102413485658.
    1. International Chiropractic Assocoation (2009) Practicing Chiropractors’ Committee on Radiology Protocols (PCCRP) for biomechanical assessment of spinal subluxation in chiropractic clinical practice.
    1. Ioannidis JP, Evans SJ, Gotzsche PC, O’Neill RT, Altman DG, Schulz K, Moher D. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141(10):781–788. doi: 10.7326/0003-4819-141-10-200411160-00009.
    1. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008;7(4):354–361. doi: 10.1016/S1474-4422(08)70062-0.
    1. Johnson C. Measuring pain. visual analog scale versus numeric pain scale: what is the difference? J Chiropr Med. 2005;4(1):43–44. doi: 10.1016/S0899-3467(07)60112-8.
    1. Jull G, Trott P, Potter H, Zito G, Niere K, Shirley D, Emberson J, Marschner I, Richardson C. A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache. Spine (Phila Pa 1976) 2002;27(17):1835–1843. doi: 10.1097/00007632-200209010-00004.
    1. Kerr FW. Central relationships of trigeminal and cervical primary afferents in the spinal cord and medulla. Brain Res. 1972;43(2):561–572. doi: 10.1016/0006-8993(72)90408-8.
    1. Knackstedt H, Bansevicius D, Aaseth K, Grande RB, Lundqvist C, Russell MB. Cervicogenic headache in the general population: the Akershus study of chronic headache. Cephalalgia. 2010;30(12):1468–1476. doi: 10.1177/0333102410368442.
    1. Leboeuf-Yde C, Fejer R, Nielsen J, Kyvik KO, Hartvigsen J. Pain in the three spinal regions: the same disorder? data from a population-based sample of 34,902 danish adults. Chiropr Man Ther. 2012;20:11. doi: 10.1186/2045-709X-20-11.
    1. Lundqvist C, Benth JS, Grande RB, Aaseth K, Russell MB. A vertical VAS is a valid instrument for monitoring headache pain intensity. Cephalalgia. 2009;29(10):1034–1041. doi: 10.1111/j.1468-2982.2008.01833.x.
    1. Lundqvist C, Grande RB, Aaseth K, Russell MB. Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus study of chronic headache. Pain. 2012;153(3):682–686. doi: 10.1016/j.pain.2011.12.008.
    1. McLain RF, Pickar JG. Mechanoreceptor endings in human thoracic and lumbar facet joints. Spine (Phila Pa 1976) 1998;23(2):168–173. doi: 10.1097/00007632-199801150-00004.
    1. Meissner K, Fassler M, Rucker G, Kleijnen J, Hrobjartsson A, Schneider A, Antes G, Linde K. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med. 2013;173(21):10. doi: 10.1001/jamainternmed.2013.10391.
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi: 10.1136/bmj.c869.
    1. Nilsson N. The prevalence of cervicogenic headache in a random population sample of 20–59 year olds. Spine (Phila Pa 1976) 1995;20(17):1884–1888. doi: 10.1097/00007632-199509000-00008.
    1. Nilsson N. A randomized controlled trial of the effect of spinal manipulation in the treatment of cervicogenic headache. J Manipulative Physiol Ther. 1995;18(7):435–440.
    1. Nilsson N, Christensen HW, Hartvigsen J. The effect of spinal manipulation in the treatment of cervicogenic headache. J Manipulative Physiol Ther. 1997;20(5):326–330.
    1. Pareira Monteriro J. Epidemiologic e clinico de uma populacäo urbana. Cefaleia: University of Porto; 1995.
    1. Rasmussen BK, Jensen R, Olesen J. Questionnaire versus clinical interview in the diagnosis of headache. Headache. 1991;31(5):290–295. doi: 10.1111/j.1526-4610.1991.hed3105290.x.
    1. Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen RA, Olesen J. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia. 1992;12(6):369–374. doi: 10.1111/j.1468-2982.1992.00369.x.
    1. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61(4):490–495. doi: 10.1001/archneur.61.4.490.
    1. Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ. Task force of the international headache society clinical trial subcommittee. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia. 2008;28(5):484–495. doi: 10.1111/j.1468-2982.2008.01555.x.
    1. Sjaastad O, Bakketeig LS. Prevalence of cervicogenic headache: vaga study of headache epidemiology. Acta Neurol Scand. 2008;117(3):173–180. doi: 10.1111/j.1600-0404.2007.00962.x.
    1. Sjaastad O, Fredriksen TA. Cervicogenic headache: criteria, classification and epidemiology. Clin Exp Rheumatol. 2000;18(2 Suppl 19):S3–S6.
    1. Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. the cervicogenic headache international study group. Headache. 1998;38(6):442–445. doi: 10.1046/j.1526-4610.1998.3806442.x.
    1. Taylor JA. Full-spine radiography: a review. J Manipulative Physiol Ther. 1993;16(7):460–474.
    1. Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ, Guidetti V, Jones B, Lipton RB, Massiou H, Meinert C, Sandrini G, Steiner T, Winter PB, International headache society clinical trial subcommittee Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20(9):765–786. doi: 10.1046/j.1468-2982.2000.00117.x.
    1. Tuchin P. A replication of the study ‘adverse effects of spinal manipulation: a systematic review’. Chiropr Man Therap. 2012;20(1):30. doi: 10.1186/2045-709X-20-30.
    1. Vernon HT. The effectiveness of chiropractic manipulation in the treatment of headache: an exploration in the literature. J Manipulative Physiol Ther. 1995;18(9):611–617.
    1. Vernon H. Qualitative review of studies of manipulation-induced hypoalgesia. J Manipulative Physiol Ther. 2000;23(2):134–138. doi: 10.1016/S0161-4754(00)90084-8.
    1. Vicenzino B, Paungmali A, Buratowski S, Wright A. Specific manipulative therapy treatment for chronic lateral epicondylalgia produces uniquely characteristic hypoalgesia. Man Ther. 2001;6(4):205–212. doi: 10.1054/math.2001.0411.
    1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2163–2196. doi: 10.1016/S0140-6736(12)61729-2.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다